KROS

15.09

5.03% -0.80

Handel nachbörslich: 15.39 0.30 +1.99%

Keros Therapeutics Inc (KROS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt KROS? Forum Prognose

Schlusskurs vom Vortag:

$15.89

Offen:

$15.74

24-Stunden-Volumen:

516.96K

Relative Volume:

1.26

Marktkapitalisierung:

$612.89M

Einnahmen:

Nettoeinkommen (Verlust:

$-168.05M

KGV:

-2.9415

EPS:

-5.13

Netto-Cashflow:

$-146.15M

1W Leistung:

-3.58%

1M Leistung:

-3.64%

6M Leistung:

+18.45%

1J Leistung:

-75.06%

1-Tages-Spanne:

$15.06

$15.89

1-Wochen-Bereich:

$15.06

$16.44

52-Wochen-Spanne:

$9.12

$72.37

Keros Therapeutics Inc Stock (KROS) Company Profile

Firmenname

Keros Therapeutics Inc

Sektor

Healthcare (1140)

Branche

Biotechnology (636)

Telefon

617-314-6297

Adresse

1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA

Mitarbeiter

148

Twitter

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

KROS's Discussions on Twitter

Vergleichen Sie KROS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
KROS Keros Therapeutics Inc	15.09	645.38M	0	-168.05M	-146.15M	-5.13
VRTX Vertex Pharmaceuticals Inc	412.22	104.45B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	469.36	60.95B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	572.60	59.11B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	812.95	49.23B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.94	35.92B	4.56B	-176.77M	225.30M	-1.7177

Keros Therapeutics Inc Stock (KROS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-06-10	Herabstufung	BofA Securities	Buy → Neutral
2025-01-21	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2025-01-17	Herabstufung	Wedbush	Outperform → Neutral
2024-12-16	Herabstufung	Guggenheim	Buy → Neutral
2024-12-16	Bestätigt	Oppenheimer	Outperform
2024-12-13	Bestätigt	H.C. Wainwright	Buy
2024-12-12	Herabstufung	BTIG Research	Buy → Neutral
2024-12-12	Herabstufung	TD Cowen	Buy → Hold
2024-12-12	Herabstufung	William Blair	Outperform → Mkt Perform
2024-11-05	Eingeleitet	Jefferies	Buy
2024-10-24	Eingeleitet	Cantor Fitzgerald	Overweight
2024-10-16	Eingeleitet	Scotiabank	Sector Outperform
2024-09-23	Eingeleitet	Guggenheim	Buy
2024-06-25	Eingeleitet	Oppenheimer	Outperform
2024-02-21	Eingeleitet	William Blair	Outperform
2023-12-08	Eingeleitet	Wells Fargo	Overweight
2023-07-31	Eingeleitet	Wedbush	Outperform
2023-07-26	Eingeleitet	BofA Securities	Buy
2023-02-14	Eingeleitet	Cowen	Outperform
2022-10-18	Eingeleitet	Truist	Buy
2022-07-26	Eingeleitet	BTIG Research	Buy
2020-12-08	Bestätigt	H.C. Wainwright	Buy
2020-05-04	Eingeleitet	H.C. Wainwright	Buy
2020-05-04	Eingeleitet	Jefferies	Buy
2020-05-04	Eingeleitet	Piper Sandler	Overweight
2020-05-04	Eingeleitet	SVB Leerink	Outperform

Alle ansehen

Keros Therapeutics Inc Aktie (KROS) Neueste Nachrichten

04:40 AM

Why Keros Therapeutics Inc. stock remains undervaluedJobs Report & Daily Entry Point Alerts - newser.com

04:40 AM

04:37 AM

Published on: 2025-10-14 03:37:04 - newser.com

04:37 AM

02:18 AM

Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

02:18 AM

12:47 PM

Can volume confirm reversal in Keros Therapeutics Inc.2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com

12:47 PM

12:27 PM

Can machine learning forecast Keros Therapeutics Inc. recoveryJuly 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com

12:27 PM

Oct 13, 2025

How to recover losses in Keros Therapeutics Inc. stock2025 Trading Recap & Scalable Portfolio Growth Methods - newser.com

Oct 13, 2025

Keros Therapeutics Inc. stock trendline breakdownTrade Analysis Summary & Reliable Price Breakout Alerts - newser.com

Oct 13, 2025

Historical volatility pattern of Keros Therapeutics Inc. visualizedJobs Report & Verified Chart Pattern Signals - newser.com

Oct 13, 2025

Published on: 2025-10-13 08:49:09 - newser.com

Oct 13, 2025

Will breakout in Keros Therapeutics Inc. lead to full recoveryInsider Selling & High Win Rate Trade Tips - newser.com

Oct 13, 2025

Forecasting Keros Therapeutics Inc. price range with options dataTrade Performance Summary & Fast Exit and Entry Strategy Plans - newser.com

Oct 13, 2025

Can trapped investors hope for a rebound in Keros Therapeutics Inc.2025 Volatility Report & Real-Time Market Trend Scan - newser.com

Oct 13, 2025

What hedge fund activity signals for Keros Therapeutics Inc. stock2025 Support & Resistance & Consistent Profit Alerts - newser.com

Oct 13, 2025

Earnings visualization tools for Keros Therapeutics Inc.Quarterly Trade Report & Smart Swing Trading Techniques - newser.com

Oct 13, 2025

Oct 12, 2025

What analysts say about Keros Therapeutics Inc stockPrice Support Zones & High Yield Trading Signals - earlytimes.in

Oct 12, 2025

Oct 10, 2025

Keros Therapeutics Inc. stock daily chart insightsMarket Volume Summary & Long Hold Capital Preservation Tips - newser.com

Oct 10, 2025

Published on: 2025-10-10 05:54:47 - newser.com

Oct 10, 2025

Weiss Ratings Reaffirms "Sell (D)" Rating for Keros Therapeutics (NASDAQ:KROS) - MarketBeat

Oct 10, 2025

Investors in Keros Therapeutics (NASDAQ:KROS) have unfortunately lost 72% over the last year - Yahoo Finance

Oct 10, 2025

Oct 07, 2025

Public Employees Retirement System of Ohio Purchases Shares of 26,103 Keros Therapeutics, Inc. $KROS - MarketBeat

Oct 07, 2025

Oct 06, 2025

Can Keros Therapeutics Inc. recover in the next quarterMarket Performance Recap & Growth Oriented Trading Recommendations - newser.com

Oct 06, 2025

Can Keros Therapeutics Inc. rally from current levelsGap Down & Weekly Market Pulse Alerts - newser.com

Oct 06, 2025

Will Keros Therapeutics Inc. bounce back from current supportQuarterly Earnings Report & Long-Term Capital Growth Strategies - newser.com

Oct 06, 2025

Oct 05, 2025

How to interpret RSI for Keros Therapeutics Inc. stockWeekly Stock Summary & Proven Capital Preservation Methods - newser.com

Oct 05, 2025

Quantitative breakdown of Keros Therapeutics Inc. recent moveTake Profit & Risk Controlled Stock Pick Alerts - newser.com

Oct 05, 2025

Oct 03, 2025

Is Keros Therapeutics Inc. stock poised for growthTrade Analysis Report & Growth Oriented Trade Recommendations - newser.com

Oct 03, 2025